OPSIRIA Trademark Information

Trademark by Santen Pharmaceutical Co., Ltd.

Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment ...

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: OPSIRIA
Status/Status Date:
REGISTERED
2/18/2020
Serial Number: 88327740
Filing Date: 3/6/2019
Registration Number: 5988035
Registration Date: 2/18/2020
Goods and Services: Collyrium; eye drops; ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions; pharmaceutical preparations for treatment of pinguecula; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; pharmaceutical preparations for improving focus-adjustment function declined by accommodative asthenopia; pharmaceutical preparations for treatment of accommodative asthenopia; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 12/3/2019
Last Applicant/Owner:
Santen Pharmaceutical Co., Ltd.
Osaka 530-8552
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
FITCH, EVEN, TABIN & FLANNERY LLP
SUITE 2100
120 SOUTH LASALLE STREET
CHICAGO IL 60603
Current Status:
REGISTERED
2/18/2020
Correspondent Search:
JOHN E. LYHUS is a correspondent of OPSIRIA trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on